Income Taxes - Schedule of Reconciliation of the Income Tax Expenses Determined at the Statutory Income Tax Rate (Details) - USD ($) |
6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Apr. 30, 2026 |
Apr. 30, 2025 |
Oct. 31, 2025 |
Oct. 31, 2024 |
Oct. 31, 2023 |
|
| Effective Income Tax Rate Reconciliation, Tax Credit, Amount [Abstract] | |||||
| Income tax computed at 25% | $ (217,032) | $ (112,353) | $ (29,825) | $ 621,030 | $ 544,135 |
| Different tax rates in other jurisdictions | 629,555 | 163,809 | 336,470 | 10,347 | 8,235 |
| Tax preferential rate | (144,500) | (19,830) | (135,251) | (253,840) | (211,285) |
| Non deductible expenses | 4,834 | 1,323 | 1,774 | 1,968 | 6,452 |
| Super deduction | (78,351) | (3,196) | (6,780) | (7,245) | (30,610) |
| Tax loss not recognised | 11,457 | 0 | 19,340 | 0 | 0 |
| Income tax expense | $ 205,963 | $ 29,752 | $ 202,900 | $ 380,767 | $ 316,927 |
| X | ||||||||||
- Definition The amount of tax loss not recognised. No definition available.
|
| X | ||||||||||
- Definition Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|